Clinical Trial Update: Improving Preterm Kidney Outcomes With Caffeine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from the University of Wisconsin–Madison is investigating caffeine to improve kidney outcomes in preterm infants; the study is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Kidney Injury, Pre-Term | Phase 2 | Status: NOT_YET_RECRUITING